Abstract
The implantable Infusaid drug pump model 100 (Shiley Infusaid, Norwood, Mass.) is undergoing trials as a drug delivery system in the treatment of osteomyelitis. This study evaluated the stability of vancomycin (1 mg/ml) incubated at 37 degrees C for 4 weeks in the pump. Both bioassay and high-pressure liquid chromatography data demonstrated a loss of at least 38% of activity over 4 weeks and colloidal precipitation of vancomycin in the pump at the end of the experiment. This study suggests that vancomycin is not stable enough for use in the Infusaid drug pump model 100.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Jehl F., Gallion C., Thierry R. C., Monteil H. Determination of vancomycin in human serum by high-pressure liquid chromatography. Antimicrob Agents Chemother. 1985 Apr;27(4):503–507. doi: 10.1128/aac.27.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mann J. M., Coleman D. L., Boylan J. C. Stability of parenteral solutions of sodium cephalothin, cephaloridine, potassium penicillin G (buffered) and vancomycin hydrochloride. Am J Hosp Pharm. 1971 Oct;28(10):760–763. [PubMed] [Google Scholar]
- Perry C. R., Ellington L. L., Becker A., Vossen M. K., Burdge R. E., Greenberg R. N. Antibiotic stability in an implantable pump. J Orthop Res. 1986;4(4):494–498. doi: 10.1002/jor.1100040413. [DOI] [PubMed] [Google Scholar]
- Perry C. R., Ritterbusch J. K., Rice S. H., Davenport K., Burdge R. E. Antibiotics delivered by an implantable drug pump. A new application for treating osteomyelitis. Am J Med. 1986 Jun 30;80(6B):222–227. doi: 10.1016/0002-9343(86)90505-x. [DOI] [PubMed] [Google Scholar]
- Sabath L. D., Casey J. I., Ruch P. A., Stumpf L. L., Finland M. Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med. 1971 Sep;78(3):457–463. [PubMed] [Google Scholar]